ControlRad Systems adds former GE exec to board of directors

Michael Walter | | Radiology Business | Leadership

Paul J. Mirabella, former president and CEO of GE Healthcare’s Global Diagnostic Imaging business, has joined the ControlRad Systems board of directors, the company announced this week.

Mirabella has more than 40 years of experience working in the healthcare industry. Besides his time with GE Healthcare, he also served as the chairman and CEO of Naviscan, an imaging start-up.

Guillaume Bailliard, ControlRad Systems president and CEO, discussed the positive impact adding Mirabella to the board of directors will have on the company’s future.

“We are thrilled that Paul has joined our board,” Bailliard said. “His experience in leading product development, service, marketing, sales and global business teams, along with his relevant industry relationships, will bring tremendous value to the company.”

ControlRad System is is a Philadelphia-based medical device company with engineering facilities in Kfar Saba, Israel. It emphasizes products that reduce radiation exposure for both patients and physicians.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

President of medical device company resigns over conduct allegations after 7 months in role
Radiology CEO discusses bankruptcy and why he’s optimistic about his company’s second-chance future
Hospitals increasingly funding their own radiology residency positions
Society of Interventional Radiology names new CEO
Frequent AI use may increase radiologists’ risk of burnout
Radiology Business Announces Forty Under 40 Class of 2024

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.